| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 22.696 | 37.301 | 29.899 | 20.972 | 36.419 |
| Total Income - EUR | - | - | - | - | 0 | 31.833 | 49.880 | 80.946 | 18.248 | 52.442 |
| Total Expenses - EUR | - | - | - | - | 15 | 29.333 | 39.645 | 79.707 | 51.273 | 54.235 |
| Gross Profit/Loss - EUR | - | - | - | - | -15 | 2.500 | 10.235 | 1.239 | -33.025 | -1.793 |
| Net Profit/Loss - EUR | - | - | - | - | -15 | 1.819 | 9.250 | 477 | -33.025 | -1.904 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio-Rah International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 110 | 0 | 11.671 | 46.864 | 87.368 | 78.309 |
| Current Assets | - | - | - | - | 65 | 10.192 | 40.446 | 53.347 | 22.429 | 41.296 |
| Inventories | - | - | - | - | 0 | 2.250 | 3.695 | 36.039 | 14.341 | 3.455 |
| Receivables | - | - | - | - | 0 | 5.613 | 10.590 | 10.154 | 3.038 | 37.632 |
| Cash | - | - | - | - | 65 | 2.330 | 26.161 | 7.154 | 5.049 | 209 |
| Shareholders Funds | - | - | - | - | 27 | 1.846 | 11.055 | 11.566 | -21.494 | -23.278 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 148 | 15.273 | 37.857 | 89.096 | 133.934 | 142.718 |
| Income in Advance | - | - | - | - | 0 | 0 | 3.205 | 490 | 0 | 2.029 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Bio-Rah International S.r.l.